Deferoxamine-d7 Trifluoroacetic Acid Salt (Major)

CAS : 162442-10-6

Ref. TR-D228982

Informations sur le produit

• Nom: Deferoxamine-d7 Trifluoroacetic Acid Salt (Major)
• Synonymes: N1-(5-Aminopentyl)-N1-hydroxy-N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]butanediamide-d7 Trifluoroacetic Acid Salt, N-[5-[3-[(5-Aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]propionohydroxamic Acid-d7 Trifluoroacetic Acid Salt, Ba 33112-d7, DFOM-d7, DFX-d7 Trifluoroacetic Acid Salt, Deferoxamine B-d7 Trifluoroacetic Acid Salt, Deferoxamine-d7 Trifluoroacetic Acid Salt, Deferrioxamine B-d7 Trifluoroacetic Acid Salt, Desferal-d7 Trifluoroacetic Acid Salt, Desferrioxamine B-d7 Trifluoroacetic Acid Salt, Desferrioxamine-d7 Trifluoroacetic Acid Salt
• Marque: TRC
• Description: Applications Deferoxamine-d7 Trifluoroacetic Acid Salt, is labelled Deferoxamine Trifluoroacetic Acid Salt (D228981), an iron chelating agent used in therapy for patients with sickle cell diseases and iron overload. Studies suggest that it can exert potential antioxidant neuroprotective effects in stroke patients.References Inati, A. et al.: Am. J. Hematol., 85, 782 (2010); Selim, M.: Translat. Stroke Res., 1, 35 (2010); Cappellini, M.D. et al.: Hemoblobin, 33, 258 (2009)

Propriétés chimiques

• Masse moléculaire: 567.74 + x(114.02)
• Formule: C₂₅D₇H₄₁N₆O₈·x(C₂HF₃O₂)
• Couleur/Forme: White To Off-White
• InChI: InChI=1S/C25H48N6O8.C2HF3O2/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26;3-2(4,5)1(6)7/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34);(H,6,7)/i1D3,12D2,14D2